Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr. Mendelson performed many of the pharmacokinetic and abuse liability studies used to support FDA approval of Suboxone®—a new primary pharmacotherapy for opiate addiction. In collaboration with engineers, Dr. Mendelson and CPMCRI scientist Dr. Gantt Galloway are developing new technologies for detecting and treating opiate overdose, and improving adherence to prescription medications using Smart phones to track and verify medication administration. The Mendelson lab is developing more efficient clinical trials methodologies, such as portable devices that automate data collection outside the research clinic.
Methamphetamine, MDMA, cocaine, methamphetamine enantiomers, marijuana, and opioids), and evaluates pharmacotherapies for addictive disorders.
Research Article: J Addict Res Ther 2011, 2:108
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals